Citi raised its price target on Puma Biotechnology (NASDAQ: PBYI) to $156.00 (from $114.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE